JGP Global Gestao de Recursos’s AbCellera Biologics ABCL Stock Holding History

JGP Global Gestao de Recursos’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,149	Closed	-$76.2K	–	49
2025 Q3	$76.2K	Sell	15,149 -2,197	-13%	-$9.68K	0.04%	33
2025 Q2	$59.5K	Hold	17,346	–	–	0.03%	42
2025 Q1	$38.7K	Sell	17,346 -5,252	-23%	-$15.1K	0.03%	32
2024 Q4	$66.2K	Hold	22,598	–	–	0.15%	37
2024 Q3	$58.8K	Buy	22,598 +4,819	+27%	+$13.4K	0.11%	38
2024 Q2	$52.6K	Hold	17,779	–	–	0.07%	37
2024 Q1	$80.5K	Buy	17,779 +362	+2%	+$1.85K	0.05%	52
2023 Q4	$99.5K	Buy	+17,417	New	+$80.7K	0.06%	48

Other funds holding ABCL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JGP Global Gestao de Recursos's ABCL Position: Q4 2025 in Review

JGP Global Gestao de Recursos sold out of AbCellera Biologics (ABCL) in Q4 2025, closing a stake of 15,149 shares — an estimated $76.2K sold.

JGP Global Gestao de Recursos first reported a position in ABCL in Q4 2023 and held it in 8 quarters. The position peaked at $99.5K in Q4 2023. 144 funds tracked by Wall St. Rank hold ABCL as of Q4 2025.

JGP Global Gestao de Recursos reported no remaining AbCellera Biologics position as of Q4 2025 after selling out during the quarter.
JGP Global Gestao de Recursos sold 15,149 AbCellera Biologics shares in Q4 2025, an estimated $76.2K.
JGP Global Gestao de Recursos first reported a position in AbCellera Biologics in Q4 2023 and held it in 8 quarters.
JGP Global Gestao de Recursos's AbCellera Biologics position peaked at $99.5K in Q4 2023.
144 funds tracked by Wall St. Rank held AbCellera Biologics as of Q4 2025.

Based on JGP Global Gestao de Recursos's 13F filing for Q4 2025, filed 26 Jan 2026.